Claro Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Sell
1,310
-15
-1% -$4.15K 0.03% 418
2026
Q1
$391K Buy
1,325
+44
+3% +$13.1K 0.05% 298
2025
Q4
$350K Sell
1,281
-1
-0.1% -$272 0.05% 295
2025
Q3
$346K Sell
1,282
-48
-4% -$13.1K 0.05% 292
2025
Q2
$367K Sell
1,330
-1,658
-55% -$451K 0.06% 254
2025
Q1
$793K Buy
2,988
+264
+10% +$65.1K 0.11% 176
2024
Q4
$633K Sell
2,724
-311
-10% -$71.5K 0.09% 210
2024
Q3
$670K Buy
+3,035
New +$628K 0.09% 224
2019
Q1
Sell
-551
Closed -$94K 290
2018
Q4
$94K Buy
+551
New +$102K 0.08% 239

Other funds holding CME

Claro Advisors's CME Position: Q2 2026 in Review

Claro Advisors reduced its CME Group (CME) stake by 1.1% in Q2 2026, selling an estimated $4.15K and leaving 1,310 shares worth $289K. The position accounts for 0.03% of the portfolio, ranked #418.

Claro Advisors first reported a position in CME in Q4 2018 and has held it in 9 quarters since. The position peaked at $793K in Q1 2025. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Claro Advisors held 1,310 shares of CME Group worth $289K as of Q2 2026.
  • Claro Advisors sold 15 CME Group shares in Q2 2026, an estimated $4.15K.
  • CME Group made up 0.03% of Claro Advisors's portfolio in Q2 2026, its #418 holding.
  • Claro Advisors first reported a position in CME Group in Q4 2018 and has held it in 9 quarters since.
  • Claro Advisors's CME Group position peaked at $793K in Q1 2025.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Claro Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.